RWJ Hamilton Joins the Jefferson Neuroscience Network
Robert Wood Johnson University Hospital Hamilton is pleased to announce it has joined the Jefferson Neuroscience Network (JNN). Through this collaboration, Jefferson and RWJ Hamilton will provide some of the most sophisticated care and expertise available to patients with time-sensitive neurovascular diseases. By joining JNN, RWJ Hamilton will now offer patients access to the resources of Jefferson’s comprehensive stroke center with leading edge clinical trials, advanced protocols and education for the detection and treatment of stroke and other neuroscience disorders.
“RWJ Hamilton is honored to be one of the first hospitals in Central New Jersey to be included in the JNN,” said Dr. Rao Pasupuleti, chief of neurology at RWJ Hamilton. “Our staff and physicians’ commitment to provide our community with high quality health care makes this collaboration possible.” In 2010 and 2011, HealthGrades ranked RWJ Hamilton among the top 5 percent of hospitals in the nation for emergency medicine where stroke care begins. RWJ Hamilton’s Stroke Program recently received Joint Commission certification for the third consecutive time.
‘Time is brain’ is the credo among healthcare professionals for diagnosing and treating time-sensitive neurovascular diseases, including arteriovenous malformations (AVMs), brain aneurysms and, especially, stroke. Certain drugs for stroke must be administered within 4.5 hours for best chance of functional recovery. Timely performance of neurological procedures to repair AVMs and aneurysms are similarly urgent.
“Stroke is the third-leading cause of death in the United States but the leading cause of disability. On average, someone suffers a stroke every 45 seconds; someone dies of a stroke every three minutes; and 795,000 people suffer a new or recurrent stroke each year,” said Rodney Bell, M.D., neurologist and co-director of the Jefferson Stroke Center.
"JNN was established to place all of our resources, among them, vascular neurologists, dual-trained neurosurgeons, advanced technology, leading clinical trials in which we partner with the National Institutes of Health, and community education on neuroscience issues, at the disposal of patients, their families and physicians of hospitals participating in the network," said Robert H. Rosenwasser, M.D., Jewell L. Osterholm, M.D., Professor and Chair, Department of Neurological Surgery at Jefferson Medical College of Thomas Jefferson University, and co-director of the Stroke Program at Thomas Jefferson University Hospital.